Jiangsu Recbio Technology Co., Ltd. (RECBIO-B) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 30 April 2026, detailing a major adjustment to its share structure.
On 29 April 2026, the company converted 129.95 million domestic shares and 12.00 million unlisted foreign shares into 141.95 million H shares. The transaction involved no new cash proceeds and represented a reclassification within the existing share capital.
Following the conversion, the number of H shares in issue increased from 316.14 million to 458.09 million, a rise of 44.90%. Domestic shares fell to 167.98 million, and all unlisted foreign shares were eliminated. Total issued share capital remained unchanged at 626.08 million shares.
The company reported no treasury shares, repurchases, or cancellations as of the closing balance date.
Director Liu Yong confirmed that the board duly authorised the conversion and that all procedures complied with Hong Kong listing rules and relevant regulatory requirements.
Comments